Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09
Titel:
Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non–Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09
Auteur:
Gautschi, Oliver Mach, Nicholas Rothschild, Sacha I. Li, Qiyu Stahel, Rolf A. Zippelius, Alfred Cathomas, Richard Früh, Martin Betticher, Daniel C. Peters, Solange Rauch, Daniel Feilchenfeldt, Jonas Bubendorf, Lukas Savic, Spasenija Jaggi, Rolf Leibundgut, Elisabeth Oppliger Largiadèr, Carlo Brutsche, Martin Pilop, Christiane Stalder, Lukas Pless, Miklos Ochsenbein, Adrian F.